Precipio logo
Precipio PRPO
$ 27.82 -0.29%

Annual report 2025
added 03-30-2026

report update icon

Precipio Long Term Debt Current 2011-2026 | PRPO

Annual Long Term Debt Current Precipio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
410 K 201 K 218 K 199 K 166 K 225 K 209 K 263 K 587 K 7.81 M 7.6 M 462 K 242 K 6.17 M 3.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
7.81 M 166 K 1.9 M

Long Term Debt Current of other stocks in the Diagnostics research industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
2.18 M - -6.23 % $ 30.6 M germanyGermany
Aspira Women's Health Aspira Women's Health
AWH
202 K - -6.19 % $ 10.5 M usaUSA
Biocept Biocept
BIOC
518 K - -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
697 K $ 1.16 -1.69 % $ 6.32 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
915 K - 0.22 % $ 16.8 M usaUSA
DermTech DermTech
DMTK
3.07 M - -11.32 % $ 2.94 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
6.52 M $ 16.69 -6.86 % $ 889 M usaUSA
Akumin Akumin
AKU
17.2 M - -17.87 % $ 25.9 M canadaCanada
Enzo Biochem Enzo Biochem
ENZ
841 K - -8.98 % $ 14.8 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
33.6 M - - $ 19.8 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
662 K $ 4.4 101.83 % $ 5.85 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
829 K - -61.36 % $ 2.46 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
1.66 M $ 23.43 -6.99 % $ 651 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
147 K - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
264 K - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
21.5 M - 0.12 % $ 80.1 M chinaChina
Charles River Laboratories International Charles River Laboratories International
CRL
57.7 M $ 175.55 0.27 % $ 8.7 B usaUSA
Danaher Corporation Danaher Corporation
DHR
199 M $ 192.99 -1.63 % $ 138 B usaUSA
Heska Corporation Heska Corporation
HSKA
2.94 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
475 K - -20.0 % $ 1.06 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
431 K $ 2.3 16.02 % $ 10.2 M usaUSA
Illumina Illumina
ILMN
79 M $ 123.67 -3.38 % $ 19.7 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
1.44 M $ 15.02 -5.12 % $ 454 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
241 M $ 28.13 0.29 % $ 20 B niderlandNiderland
Guardant Health Guardant Health
GH
27.7 M $ 87.17 -6.11 % $ 10.9 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
23.4 M - - $ 10.6 B niderlandNiderland
Anixa Biosciences Anixa Biosciences
ANIX
41 K $ 2.74 0.37 % $ 88.9 K usaUSA
Biomerica Biomerica
BMRA
358 K $ 2.2 2.33 % $ 5.05 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
24.3 M $ 106.7 0.15 % $ 8.8 B irlandaIrlanda
Check-Cap Ltd. Check-Cap Ltd.
CHEK
264 K - - $ 9.42 M israelIsrael
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
191 M $ 273.26 -0.53 % $ 22.7 B usaUSA
Celcuity Celcuity
CELC
54 K $ 124.64 6.58 % $ 5.83 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
23.2 M $ 501.5 -3.68 % $ 14.5 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
3.8 M $ 81.43 1.75 % $ 5.5 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
169 K - -34.28 % $ 263 K israelIsrael
Myriad Genetics Myriad Genetics
MYGN
6.9 M $ 4.44 -6.92 % $ 411 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
174 M $ 197.82 -0.5 % $ 22 B usaUSA
NeoGenomics NeoGenomics
NEO
4.78 M $ 7.94 -3.38 % $ 1.02 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
5.64 M $ 10.04 -2.95 % $ 2.18 B usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
129 K $ 5.31 2.71 % $ 4.18 M usaUSA
National Research Corporation National Research Corporation
NRC
451 K $ 17.05 -1.22 % $ 382 M usaUSA
Natera Natera
NTRA
7.64 M $ 203.0 -3.71 % $ 20 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
14.6 M - - $ 21.2 M usaUSA
Organovo Holdings Organovo Holdings
ONVO
521 K - -2.3 % $ 19.4 M usaUSA
OpGen OpGen
OPGN
174 K - -16.95 % $ 1.54 M usaUSA